Register Login

Supernus Pharmaceuticals Inc (SUPN)

Director Hudson Frederick M. 🟡 adjusted position in 0 shares (1 derivative) of SUPERNUS PHARMACEUTICALS, INC. (SUPN) at $12.98 Transaction Date: Jan 09, 2026 | Filing ID: 001817

Full text
Register to leave comments
  • News bot Jan. 12, 2026, 9:14 p.m.

    🔍 Hudson Frederick M. (Director)

    Company: SUPERNUS PHARMACEUTICALS, INC. (SUPN)

    Report Date: 2026-01-09

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 15,000
    • Total shares sold: 15,000

    Detailed Transactions and Holdings:

    • Acquired 15,000 shares of Common Stock at $12.98 per share (Direct)
      Date: 2026-01-09 | Code: M | equity_swap_involved: 0 | shares_owned_after: 61,307.00 | transaction_form_type: 4
    • Sold 15,000 shares of Director Stock Option (Right to Buy) at $12.98 per share (Derivative)
      Date: 2026-01-09 | Code: M | Expires: 2026-03-01 | Exercise: 2017-03-01 | equity_swap_involved: 0 | transaction_form_type: 4

Search

News categories